NASDAQ:CELU

Celularity News Headlines

$7.10

-0.36 (-4.83%)

(As of 05/23/2022 04:00 PM ET)

Add

Compare

Today's Range: $7.10
▼
$7.88
50-Day Range: $5.77
▼
$12.91
52-Week Range: $3.63
▼
$13.40

Volume: 330,835 shs
Average Volume: 270,448 shs
Market Capitalization: $977.82 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: -0.4

Get Celularity News Delivered to You Automatically

Media Mentions By Week

Celularity Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CELU
News Sentiment
▼
-0.31

0.30
▲
Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CELU Articles
This Week
▼
11

1
▲
CELU Articles
Average Week

Celularity (NASDAQ:CELU) News Headlines Today

Source

Source	Headline
	Oppenheimer Comments on Celularity Inc.'s FY2022 Earnings (NASDAQ:CELU) marketbeat.com - May 19 at 6:44 AM
	FY2022 Earnings Estimate for Celularity Inc. (NASDAQ:CELU) Issued By Oppenheimer americanbankingnews.com - May 20 at 2:24 AM
	Celularity Inc. Announces $30 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewswire globenewswire.com - May 18 at 6:31 PM
	Celularity Inc. Announces $30 Million Private Placement Priced At-The-Market Under Nasdaq Rules finance.yahoo.com - May 18 at 6:31 PM
	Celularity Reports First Quarter 2022 Financial Results and Provides Corporate Update - Yahoo Finance finance.yahoo.com - May 16 at 8:41 PM
	Celularity Reports First Quarter 2022 Financial Results and Provides Corporate Update finance.yahoo.com - May 16 at 8:41 PM
	Celularity (NASDAQ:CELU) Shares Gap Up to $5.77 americanbankingnews.com - May 15 at 1:42 AM
	Head-To-Head Contrast: Lyell Immunopharma (NASDAQ:LYEL) versus Celularity (NASDAQ:CELU) americanbankingnews.com - May 14 at 1:34 AM
	Inotiv, TScan Therapeutics top healthcare gainers; Opiant, Renovacor lead losers' pack - Seeking Alpha seekingalpha.com - May 13 at 1:04 PM
	Thinking about buying stock in Affirm Holdings, Celularity, Robinhood Markets, Endeavor Group, or Toast? - Benzinga benzinga.com - May 13 at 1:04 PM

	Global Amniotic Membrane Market (2022 to 2028) - Potential Use in Tissue Engineering Applications Presents Opportunities - ResearchAndMarkets.com - Business Wire businesswire.com - May 12 at 3:00 PM
	Celularity Says On April 29 Received Email Notification From FDA Regarding CYCART-19 IND; FDA Says It Wil - Benzinga benzinga.com - May 3 at 10:35 PM
	Celularity (NASDAQ:CELU) Shares Gap Down to $12.91 americanbankingnews.com - May 1 at 2:22 AM
	Celularity Inc. (CELU) uk.finance.yahoo.com - April 30 at 12:05 AM
	Celularity: Funds Infusion Needed ASAP To Advance seekingalpha.com - April 26 at 1:30 PM
	Truist Securities Downgrades Celularity to Hold benzinga.com - April 6 at 11:28 AM
	Celularity GAAP EPS of -$0.03, revenue of $4.86M seekingalpha.com - March 31 at 9:59 PM
	Celularity Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update finance.yahoo.com - March 31 at 4:59 PM
	Advanced Wound Care Market Report Analysis, Share, Revenue, Growth Rate With Forecast Overview To 2028 marketwatch.com - March 30 at 8:53 PM
	Bioactive Materials Market is Likely to Expand at a Projected CAGR of 11.3% during by 2032- Exclusive Report by Fact.MR nz.finance.yahoo.com - March 25 at 2:03 AM
	Scilex Holding Company, a Majority-Owned Subsidiary of tmcnet.com - March 17 at 5:47 PM
	What Percentage Of Celularity Inc. (NASDAQ:CELU) Shares Do Insiders Own? finance.yahoo.com - March 15 at 5:39 PM
	Celularity to Present at Oppenheimer 32nd Annual Healthcare Conference finance.yahoo.com - March 15 at 5:39 PM
	Perrigo (PRGO) Q4 Earnings Beat as Cough & Cold Sales Recover sg.finance.yahoo.com - March 8 at 1:48 PM
	Celularity Receives Orphan Drug Designation from U.S. FDA for its NK Cell Therapy CYNK-101 in Development for the First-Line Treatment of Advanced HER2/neu Positive Gastric and Gastroesophageal Junction Cancers finance.yahoo.com - February 15 at 7:34 PM
	Is Celularity, Inc. (CELU) Outperforming Other Medical Stocks This Year? nasdaq.com - February 11 at 11:51 AM
	Oppenheimer Initiates Coverage On Celularity with Outperform Rating, Announces Price Target of $9 benzinga.com - January 28 at 9:43 AM
	Starr International Co Inc Buys Celularity Inc, Sells Moderna Inc, AstraZeneca PLC, Johnson ... finance.yahoo.com - January 27 at 8:21 PM
	C V Starr & Co Inc Buys Celularity Inc finance.yahoo.com - January 27 at 8:21 PM
	Celularity falls 7% despite FDA fast track status for CYNK-101 in gastric cancers seekingalpha.com - January 18 at 4:21 PM
	Celularity Receives Fast Track Designation from U.S. FDA for its NK Cell Therapy CYNK-101 in Development for the First-Line Treatment of Advanced HER2/neu Positive Gastric and Gastroesophageal Junction Cancers finance.yahoo.com - January 18 at 11:20 AM
	Celularity Inc - Class A Shares Approach 52-Week Low - Market Mover nasdaq.com - January 13 at 8:35 AM
	Celularity Receives Fast Track Designation from U.S. FDA for its NK Cell Therapy CYNK-001 in Development for the Treatment of AML finance.yahoo.com - December 27 at 10:07 AM

	Analysts' Revenue Estimates For Celularity Inc. (NASDAQ:CELU) Are Surging Higher finance.yahoo.com - December 15 at 2:25 PM
	Celularity Presents Preclinical Data On Allogeneic Genetically Modified Natural Killer And Allogeneic CAR-NK Cell Therapy Programs At ASH 2021 benzinga.com - December 13 at 12:02 PM
	Celularity Presents Preclinical Data on Allogeneic Genetically Modified Natural Killer (NK) and Allogeneic CAR-NK Cell Therapy Programs at the 63rd American Society of Hematology Meeting and Exposition finance.yahoo.com - December 13 at 12:02 PM
	Celularity Announces FDA Clearance of Investigational New Drug Application (IND) for Natural Killer Cell Therapy CYNK-101 in First-line Advanced Her2/neu Positive Gastric and Gastroesophageal Junction Cancer finance.yahoo.com - November 29 at 8:31 AM
	Celularity (NASDAQ:CELU) investors are sitting on a loss of 34% if they invested a year ago finance.yahoo.com - November 16 at 8:51 AM
	Celularity Presents Preclinical Data on Allogeneic Genetically-Modified Natural Killer Cells at the Society for Immunotherapy of Cancer 36th Annual Meeting finance.yahoo.com - November 15 at 12:19 PM
	Celularity Reports Third Quarter 2021 Financial Results and Corporate Update finance.yahoo.com - November 12 at 5:59 PM
	Cramer's lightning round: I like Blade Air Mobility over Joby Aviation msn.com - September 21 at 11:43 PM
	Celularity Hires Andrew Pecora as President marketwatch.com - September 16 at 9:14 PM
	Celularity Appoints Andrew L. Pecora, M.D., F.A.C.P., C.P.E., as President finance.yahoo.com - September 16 at 9:14 PM
	The Genius Behind Palantir's SPAC Investments msn.com - August 29 at 4:55 PM
	GT Biopharma Announces the Promotion of Dr. Gregory Berk to President of Research & Development and Chief Medical Officer markets.businessinsider.com - August 23 at 9:30 AM
	Celularity Reports Second Quarter 2021 Financial Results au.finance.yahoo.com - August 16 at 5:22 PM
	Genting Bhd's biotechnology arm strikes partnership with Australia-listed firm msn.com - August 6 at 3:56 AM
	Why the Imugene (ASX:IMU) share price is charging higher on Thursday msn.com - August 4 at 8:22 PM
	Celularity Inc. Warrant (CELUW) nasdaq.com - August 2 at 5:50 PM
	Celularity Inc. Wt barrons.com - July 26 at 12:02 AM
	Celularity Inc. wsj.com - July 23 at 11:00 PM

Get Celularity News Delivered to You Automatically

This page was last updated on 5/23/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources